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Abstract
Hammond, Kelley Grace. M.S. The University of Memphis. May 2010. Central versus peripheral
manifestations of neuromuscular force production in persons with Parkinson’s disease. Major Professor:
Brian K. Schilling, Ph.D.
Bradykinesia and reduced neuromuscular force exist in Parkinson’s disease (PD). Percutaneous
electrical stimulation (PES) has been used to evaluate central versus peripheral manifestations of
neuromuscular strength in healthy, aging, and athletic populations, but this method has not previously been
used in PD. This pilot study used PES of the quadriceps femoris to identify central and peripheral
activation in persons with PD (n = 7) and neurologically healthy controls (n = 6). Maximal voluntary rate
of force development (PD = 2544N/s ± 1183, control = 4599N/s ± 1077; P = 0.008) and the rate of force
development ratio (RFDR; PD = 0.45 ± 0.15, control = 0.80 ± 0.20; P = 0.004) were significantly (P <
0.05) lower in the PD group compared to controls. No other significant differences were found between
groups. This study was the first to quantify the central deficits caused by PD which bring about reduced
neuromuscular rate of force development.
Key words: neuromuscular disease; strength deficits; percutaneous electrical stimulation; central activation
ratio
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PREFACE
This thesis was written in article format for submission to the journal Movement Disorders following
defense. The content and organization of this thesis represent and fulfill the requirements for submission to
this journal.
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INTRODUCTION
Parkinson’s disease (PD) is a central nervous system disorder that results in several debilitating
symptoms. Among these symptoms are reduced neuromuscular strength and bradykinesia (slowness of
movement)1. These difficulties with motor control evolve deep within the brain in the substantia nigra,
where dopaminergic neurons are killed by the disease. Because dopamine is a neurotransmitter that
regulates movement, persons with PD are unable to control movement via signaling from the brain to the
body’s periphery in the same manner as healthy persons do. Symptoms include, but are not limited to,
tremor of the hands, arms, legs, jaw, and face, rigidity (stiffness) of the limbs and trunk, bradykinesia, and
postural instability (impaired balance and coordination)2. Parkinson’s disease is chronic and progressive.
More Americans (~1 million) suffer from PD than Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease),
multiple sclerosis, and muscular dystrophy combined, and the yearly cost of treatment and loss of ability to
work is estimated at 25 billion dollars in the United States alone3.
Most studies comparing persons with PD to neurologically healthy, age-matched individuals have
reported reduced strength in PD4-13. This supports the presumption that decreased strength is caused by the
disease6. Corcos et al.7 and Nallegowda et al.4 reported reduced voluntary strength and rate of force
development (RFD) following withdrawal from antiparkinson medication, which suggests that this
weakness and reduction in RFD is a direct result of the disease, and that at least part of the weakness is
central in nature. While neurologically healthy persons typically take less than one second to achieve peak
force, PD patients with moderate bradykinesia can take 3-4 seconds4,7. Further, Corcos et al.7 concluded
that changes in strength correlate significantly with changes in contraction rate.
Central and peripheral effects of the disease include decreases and irregularities in motoneuron
firing rates and deficits in muscular strength5,14. Superimposed electrical stimulation is an effective method
of evaluating and quantifying voluntary versus involuntary muscle activity15-17, but has not been used in
PD. By stimulating a relaxed muscle, the maximal involuntary rate of force development (MIRFD) can be
identified and used to estimate the aptitude of the muscle’s contractility without central input. If this evoked
twitch is added to a maximal voluntary contraction (MVC), the difference in force output can provide a
quantitative value of central activation. One method of calculating this deficit is the central activation ratio
(CAR = MVC/(MVC + stimulated force))18. The purpose of this study was to collect pilot data that
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quantified the neurological deficiencies in persons with PD and observe the sources of reduced strength in
this population and establish a protocol for future studies.
METHODS

Subjects
Thirteen men (n = 10) and women (n = 3) were recruited to participate in the study. The seven
persons in the PD group (M=6, F=7) were diagnosed with idiopathic PD. Individuals with orthostatic
hypotension, dementia (Mini-Mental State Examination Scores <24), or other significant co-morbidities
(i.e., stroke, severe degenerative osteoarthritis) were not recruited into the study. Further, great care was
taken to exclude individuals with other causes of Parkinsonism such as progressive supranuclear palsy,
vascular PD, and multiple system atrophy. A board-certified neurologist rated each PD subject according to
the Unified Parkinson’s Disease Rating Scale (UPDRS) close to the time of testing.
Six neurologically healthy, age-similar individuals (M=4, F=2) were recruited from the local
university faculty and staff for the control group. These subjects were of good general health based on self
report and had no abnormal neurological diagnoses. All subjects completed a health history, drug usage,
and fitness activity questionnaire, and provided written informed consent prior to data collection (see Table
1). All testing was approved by the university institutional review board for human subjects research.

Table 1. Descriptive Statistics
Gender
Age (yr)
Height (cm)
Weight (kg)
Thigh Circumference (cm)
Thigh Skin Fold (mm)
Thigh Cross-sectional Area (cm2)
Maximum Voltage (mV)
UPDRS
Hoehn and Yahr Staging
Disease Duration

PD (n = 7)
M = 6, W = 1
65.4±7.3
177.7±8.7
84.9±6.5
52.6±5.4
22.6±11.1
56.3±19.7
283.3±25.8
15.7±5.0
HY1.5, n=1; HY2, n=6
7.9±5.01
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CONTROL (n = 6)
M = 4, W = 2
60.5±4.9
174.6±6.8
81.1±14.2
52.9±5.1
25.5±15.8
59.3±7.8
271.4±56.7
N/A
N/A
N/A

Procedures
Upon arrival to the laboratory, subjects filled out a health history, medication, and fitness activity
questionnaire after providing written informed consent. Additionally, investigators verbally obtained
informed consent and answered any questions subjects had pertaining to the study. Subjects’ height and
weight as well as thigh skinfold and circumference were measured (right leg). Skinfold and circumference
were used to calculate quadriceps femoris cross-sectional area (CSA) according to the equation by Housh et
al.19 ([2.52 x mid-thigh circumference in cm] – [1.25 x anterior thigh skinfold in mm] – 45.13). Pairs of
round Ag-AgCl surface electrodes (Ambu Blue Sensor SP, 20 mm interelectrode distance) were affixed on
the biceps femoris, vastus lateralis, and rectus femoris according to SENIAM guidelines20, with a ground
electrode placed on the patella. Vastus medialis electrodes were placed just proximal to the anode of the
stimulating electrode pair. Electrodes were placed parallel to the relaxed pennation angle of each muscle
and had an inter electrode distance of 30 mm. Prior to electrode placement, skin was shaved, vigorously
abraded, and cleaned with alcohol. EMG was recorded during every trial using Myopac Jr (RUN
Technologies; Mission Viejo, CA) with four dual-lead channels. This system has a common mode
rejection of 90 dB, a band-pass filter (10-1000 Hz), and input impedance of 10 MΩ. Data were collected at
1 kHZ and synchronized with the force signal. The EMG electrode leads were connected to a channel
amplifier/encoder/fiber optic transmitter (Myopac Jr, Run Technologies) to obtain EMG signals, which
were acquired via analog/digital conversion (Measurement Computing) at a sampling rate of 1000Hz
utilizing Datapac5 software for processing and analysis.
The subjects were seated in a customized chair which provided back support and placed the
subject in an upright position21. Seatbelt restraints were placed across the subject’s trunk and lap to
minimize movement of the torso17,21-24. Rubber stimulating electrodes (7.5 x 13 cm) were secured with tape
over the femoral triangle (cathode) and just above the superior border of the patella (anode)14,17,21,22,25-28.
The subject’s right ankle (all subjects were right-leg dominant) was inserted into a padded sleeve and cuff,
and attached to the load cell (Transducer Techniques® MLP-1K load cell) with enough tension to eliminate
slack22,23,25. This fixed the knee at 90°, and the hips at 100° (see Fig.1).
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Subjects were instructed to cross their arms over their chest during testing. For the first trial,
subjects were asked to relax prior to being given a 200µs16 triplet pulse of 50mA at 400v29 (Digitmer®
DS7AH) to the quadriceps14. The amperage was then increased in 50mA increments for subsequent trials16
until the peak force reached a plateau (less than 5% change15), which was expected to occur between 200400mA23,30,31. An octet pulse was administered at the parameters that caused plateau in force to identify
MIRFD30. Subjects were given as much time as they needed between twitches, which was less than one
minute14,15.
The subject was then instructed to maximally contract the quadriceps of their restrained leg to
familiarize the feeling of performing MVCs. Two MVCs were performed with one minute rest between
trials or when subject was ready to continue (see Fig. 2). The investigators then repeated the instructions for
the MVC, and the subject was asked to perform a MVC where the predetermined triplet pulse (same
maximal parameters) was applied during the plateau phase14,16,30,32. The MVC with stimulation trial was
repeated twice25, with a minute break between each repetition, or until the subject was ready to continue.
The better of two trials was used for analysis. Reliability of this protocol has been previously established in
the literature17,33,34.
Force signals were acquired via analog/digital conversion (Measurement Computing) utilizing
Datapac5 software for both acquisition and processing. The force signal was filtered through a fourth-order
Butterworth low-pass filter with a cutoff frequency of 30Hz. The maximal RFD during electrically
stimulated (MIRFD) and MVC (MVRFD) were calculated as the maximum velocity of the signal (N/s)
during the rise phase. Start of the action was defined as the point at which the first derivative of the filtered
force signal crossed zero for the last time. The rate of force development ratio (RFDR) was calculated as
the quotient of MVRFD divided by MIRFD.
Statistics
Because of the pilot nature of this study, simple independent t-tests were used to compare MVF,
seated isometric twitch force (SITF), MVRFD, MIRFD, CAR, RFDR, and rmsEMG between the groups.
Effect sizes were calculated to determine the magnitude of differences between groups. Bivariate
correlations were not run because there was no spread in the UPDRS data. Data were analyzed using SPSS
16.0 software.
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RESULTS
Eighteen subjects were brought in for testing, however, two did not finish the protocol due to
discomfort and three of the subject’s data were not useable due to impact artifact in the force channel. We
found significant differences between groups in MVRFD (PD = 2544.7N/s ± 1183.6, CTRL = 4598.9 ±
1076.8; P = 0.008; see Fig. 3) and RFDR (PD = 0.45 ± 0.15, CTRL = 0.80 ± 0.20; P = 0.004; see Fig. 4),
with the PD group having reduced scores compared to controls. No significant differences were found
between groups for all other notable variables, including MIRFD (PD = 6145.2N/s ± 2641.3, CTRL =
5836.8N/s ± 959.7; P = 0.79; see Fig. 5), SITF (PD = 697.6N ± 86.4, CTRL = 679.2N ± 108.2; P = 0.74;
see Fig. 6), MVF (PD = 690.7N ± 85.2, CTRL = 665.9N ± 98.1; P = 0.64; see Fig. 7), and CAR (PD = 0.99
± 0.03, CTRL = 0.98 ± .03; P = 0.63; see Fig. 8). There was no difference in voluntary activation
(rmsEMG; Fig. 9) of the biceps femoris (PD = 209.97mV ± 50.6, CTRL = 275.59mV ± 128.3; P = 0.24),
vastus lateralis (PD = 238.52mV ± 90.4, CTRL = 259.66mV ± 142.0; P = 0.75), rectus femoris (PD =
147.51mV ± 95.0, CTRL = 178.0mV ± 78.1; P = 0.95), and vastus medialis (PD = 187.27mV ± 70.8,
CTRL = 213.74mV ± 95.9; P = 0.60). Large effect sizes were found for RFDR (d = 2.03), biceps femoris
rmsEMG (d = 1.84), and MVRFD (d = 1.82).
DISCUSSION
This is the first investigation using PES to determine involuntary neuromuscular activation in PD.
We have employed a PES protocol that has been established in other populations, but is novel in PD. We
observed significant deficits in the PD group’s MVRFD and RFDR of the quadriceps femoris (QF)
compared to healthy, similar age controls. Because the intent of this study was to collect pilot data, the
sample size was small, and may be a limitation to our findings. This, paired with the high level of
functioning of the subjects could have affected the overall results of the study—in particular the strength
(MVF) measures. It should be noted that small effect sizes were noted in cases of no significant difference
between groups.
As PD progresses, bradykinesia is commonly a troublesome symptom which adds to the difficulty
of activities of daily living (ADL). Because MIRFD was similar for PD and controls, the mechanisms
responsible for this deficit early in the disease appear to be purely central in nature. The PES-induced
activation of the QF demonstrates the peripheral ability of the muscles to function, but the individuals with
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PD were unable to actively replicate the voluntary RFD of healthy controls. Other investigations of strength
measures reported similar findings of reduced voluntary RFD in persons with PD4,7,10, but this is the first to
examine MIRFD in evoked contractions. Corcos et al.7 found a correlation between maximal strength and
RFD and Allen et al.35 found similar deficits, reporting decreased leg strength and power (force x velocity)
in PD compared to controls, whereas our results only suggest a difference in RFD. Allen et al.36 also
investigated the relationship between reduced muscle power, slower walking velocity, and falling in PD,
reporting that muscle power, compared to muscle strength, greatly affected walking velocity, and had
stronger associations to falling than muscle strength alone. This indicates that the rate (velocity) at which
force can be produced is as important as the force of muscle contraction36, and both should be considered
when designing training protocols.
Initial strength improvements consequent to resistance training appear to be largely accounted for
by neural adaptations37. Del Olmo et al.38 specifically reported an adaptation in the central nervous system
following resistance training, and confirmed the sustainability of this adaption with chronic training.
Carroll et al.39 found similar results, and proposed that resistance training alters the organization of the
central nervous system so that a given magnitude of corticospinal input activates fewer motoneurons
during muscle contraction than were recruited prior to training, and the maximal voluntary force is
greater38.
To date no PD resistance training studies have specifically trained (and tested) subjects with the
objective of increasing RFD. Schilling et al.8 did instruct the subjects to “lift the weight as fast as possible
with good form”, which has not been emphasized in the other literature to date. The literature on the effects
of resistance training on RFD in healthy populations proposes that RFD is trainable over time40,41, but
emphasizes the importance of the intent of moving the load quickly. Behm and Sale40 indicated that RFD
can be increased by trying to move rapidly when moving heavy loads, in which case the actual velocity of
the movement would be slow. This seems to correspond well with training prescriptions for improving
maximal strength as well (high weight, moderate repetition). Also, instruction for the desired movement
should be highly specific, asking the subject to perform the exercise (concentric portion) as fast as
possible42.
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The PD group’s CAR scores and peak force measures were similar to the control group, even
when adjusted for QF CSA. Full activation of the QF has been reported by several studies30,43-45, so the
CARs being nearly 100% in the controls was not unfounded. As strength deficits were expected in this
investigation, CAR scores for PD were also expected to be lower than controls, but the lack of differences
in MVF may have translated to no differences in CAR. Also, our findings did not suggest reduced strength
in the PD group, although several studies have reported decreased strength in persons with PD compared to
controls4-13. Our hypothesis included similar strength deficits, but it is possible that our findings are a result
of the PD group having only mild to moderate PD (UPDRS = 15.7 ± 5.0; H&Y = 1.9 ± 0.20) and minimal
presence of symptoms when optimally medicated (as they were during testing). While our results did not
agree with previous investigations for these strength variables, the literature has considerable agreement
that reduced strength is a symptom of PD and this implies the value of resistance training interventions for
this population1,46.
Several resistance training studies have revealed increases in strength in persons with PD
following 8-12 weeks of training8,47-51. Despite considerable differences in mode, intensity, volume, and
frequency of resistance training in this population, all studies have reported increases in strength indices,
which is promising. Still, the optimal resistance prescription has yet to be identified, and none of the
aforementioned studies used RFD as an outcome measure. This prescription should specify the
aforementioned training variables for persons with PD and indicate appropriate progression of training to
optimize benefits and minimize fatigue.
Percutaneous electrical stimulation could enable quantitative measures of involuntary activation
for the manipulation of numerous variables ranging from medication dose to the effects of exercise and
physical therapy training programs. This pilot study identifies the efficacy of the PES protocol as an
evaluation method for quantifying central versus peripheral neuromuscular RFD deficits in persons with
PD. Using PES for pre- and post-testing in training interventions would establish a quantitative assessment
for evaluating training protocols for persons with PD. This is especially critical in a time when exercise is
becoming a more commonly investigated supplemental therapy for managing the progression and
symptoms of the disease, and the optimal exercise prescription has yet to be found. Our investigation used
PES to quantify QF activation (CAR), maximal strength (MVF), RFD (MVRFD and MIRFD), and RFDR.
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The PD subjects had decreased MVRFD and RFDR, as they were unable to voluntarily produce force at the
same rate as age-similar, healthy controls. We did not find significant differences in MVF, despite reports
of this deficit in the current literature, which we attribute to a combination of small sample size and high
function of the PD subjects. As investigations of exercise interventions are being proposed more frequently,
a quantitative evaluation protocol, compared to qualitative testing and questionnaires, such as PES would
be most advantageous for providing consistent comparisons among individual subjects and intervention
protocols and examining central adaptations.
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Appendix A – Figures

Fig. 1. Testing set-up for percutaneous electrical stimulation

Fig. 2. Voluntary and involuntary rate of force development
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Fig. 3. Maximal voluntary rate of force development (Mean ± SD) for PD (2544.7N/s ± 1183.6) and CNTL
(4598.9N/s ± 1076.8). Significant differences were noted between groups (P = 0.008, d = 1.82)

Fig. 4. Rate of force development ratio (Mean ± SD) for PD (0.4 5± 0.15) and CNTL (0.80 ± 0.20).
Significant differences were noted between groups (P = 0.004, d = 2.07)
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Fig. 5. Maximal involuntary rate of force development (Mean ± SD) for PD (6145.2N/s ± 2641.3) and
CNTL (5836.8N/s ± 959.7). No significant difference was noted between groups (P = 0.792, d = 0.17)

Fig. 6. Maximal involuntary force (Mean ± SD) for PD (697.57N ± 86.4) and CNTL (679.2N ± 108.2). No
significant difference was noted between groups (P = 0.739, d = 0.19)
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Fig. 7. Maximal voluntary force (Mean ± SD) for PD (690N ± 58.2) and CNTL (655.9N ± 98.1). No
significant difference was noted between groups (P = 0.636, d = 0.27)

Fig. 8. Central activation ratio (Mean ± SD) for PD (0.99 ± 0.03) and CNTL (0.98 ± 0.03). No significant
difference was noted between groups (P = 0.634, d = 0.27)
16

Appendix A – Extended Literature Review
Resistance training places significant amounts of stress on the muscles involved in the training
program. As a result, many physiological adaptations occur within the body in response to the new
demands placed on the muscles. The initial changes in strength are due to neurological adaptations that
occur both at the muscle and peripheral nervous system as well as in the brain and spinal cord (central
nervous system). The most effective evaluation method of the activity within the muscle is through
superimposed electrical stimulation. When the muscle is relaxed, an electrically evoked, involuntary
contraction can be used to estimate the capacity of the muscle’s contractility. If the subject voluntarily
maximally contracts the muscle and an electrical stimulus is added to that, central activation deficiencies
can be measured. If no additional recruitment is noted, the subject is able to maximally recruit that
musculature.
Although an abundance of studies have evaluated the methods of evoked contractions, only a
small number of those have investigated neurological changes that occur as a result of resistance training.
Consistent baseline measures have become available through testing healthy subjects, and new research can
now be conducted to examine specific aspects of the neurological maladaptations taking place due to
disease. With sufficient review, this may become an innovative tool for evaluating special populations such
as those with neuromuscular disorders.
ELECTRIC STIMULATION AS TECHNIQUE FOR MEASUREMENT
Interpolated Twitch
When determining levels of activation within the muscles, one of the most common techniques is
superimposing electrical stimulation (ES) on the target muscle or the nerve that innervates the targeted
muscle. The goal of the interpolated twitch technique (ITT) is to stimulate the nerve innervating the
targeted muscle to determine the percentage of the muscle that can be recruited involuntarily. ITT identifies
the difference between activation of the muscle with superimposed twitch at rest and activation of the
muscle during maximal voluntary contraction (MVC) with the same superimposed twitch1,2. Motor unit
(MU) activation has been evaluated in many studies using two methods which include ITT torque and the
central activation ratio (CAR). ITT torque is reported as the amplitude in the force from the supramaximal
twitch, whereas CAR is the ratio of ITT torque to the maximal voluntary torque level that immediately
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preceded the delivery of the supramaximal stimulus 3. When compared to the CAR method, ITT torque
resulted in higher sensitivity to joint-angle changes and decreased sensitivity to changes in number of
stimuli2.
Effect on different muscles
Each muscle within the human body has its own specific make-up of MU and filaments in order to
most efficiently carry out specialized movements. Also, despite systematic activation of MUs according to
Henneman’s size principle, the areas of the muscle are recruited at random due to the distribution of the
MU fibers in the cross-section of the muscle. Thus, several muscles and muscle groups have produced
different responses to ITT. The most commonly studied have been the adductor pollicis, biceps brachii,
triceps surae (gastrocnemius and soleus), and quadriceps femoris, in addition to the tibialis anterior.
According to some studies4,5 not all of these muscles are able to be fully activated voluntarily, while others
have consistently reported that the quadriceps femoris are typically capable of achieving maximal
activation1,6. The differences in these findings are dependent on several variables including stimulation
technique, location of stimulation, and intensity of stimulation. Specifically, converse outcomes have been
reported when describing results using the percutaneous superimposed electrical stimulation technique
(stimulating the muscle belly) versus the interpolated twitch technique (stimulating the muscle nerve).
Also, the discrepancies in the maximal performance of the muscles could be due to differing distributions
of fiber types within each individual muscle 5.
Variables measured
When assessing data from the ITT, several variables are available to measure and report. Among
these are resting twitch torque, which can be measured using an isokinetic/isometric dynamometer or a
force transducer 3. Maximal voluntary torque is reported using the same protocol as previously described,
but is measured during MVC versus at rest with an involuntary contraction. Either measure of maximal
evoked torque (resting or voluntary) involves percutaneous stimulation of the muscle which is particularly
uncomfortable for the instant the stimulus is applied. Maximal rate of torque development is the change in
force over the change in time. CAR is the ratio of MVC to total torque. Also, maximal firing rate was
reported in several studies, referring to assessment of maximal motor unit action potentials which were
measured using a needle electrode placed within the muscle belly 3. The torque time integral is typically
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measured at 40ms (TTI40). The TTI40 is the area under the curve on the torque-time graph from 0-40
seconds. The results of this variable are noteworthy Lastly, force has often been reported as absolute and
relative rate of force development and maximal voluntary force (MVF).
Variables concerning special populations
Presently, all known studies using the ITT have used healthy subjects for their research. Although
there have been studies that have evaluated fatigued muscles and musculoskeletal injuries, none to date
have reported the use of ITT on special populations. Bampouras et al.2 and Kendall et al 7 suggested that
when neural activation is accurately assessed during maximal efforts, new studies could evaluate the extent
of neurological damage causing inactivation of skeletal muscles due to neuromuscular diseases2,7.
Variance between men and women
Although many studies have included both men and women in their investigations involving
interpolated twitch and related stimulation techniques, there are few reports on gender differences. A study
by Kramer 8 included findings of trends which suggested differences in the results of men and women. His
explanations for variation included different proportions of large muscle fibers and distinction in sensitivity
via cutaneous impedance 8. Additionally, Maffiuletti et al 9 reported that women had a lower sensory
threshold than men and required lower amplitude of stimuli to achieve supramotor threshold. The data
collected in this study suggested that women have a higher sensory and supramotor excitability to
cutaneous electrical stimulation 9.
Muscles stimulated
As protocols and technology for electrical stimulation have evolved over the last two decades, four
muscles have been studied extensively, including the adductor pollicis, biceps brachii, triceps surae, and
quadriceps femoris. Because the adductor pollicis is a small muscle with limited surface area to stimulate,
investigators have primarily used the ulnar nerve as opposed to the muscle belly. Cannon and Cafarelli 10,
Herbert and Gandevia 11, and Bigland-Ritchie et al.12 followed similar methods by restraining the arm with
the palm facing medially and placed the electrode directly over the ulnar nerve on the distal anterior side of
the forearm.
The biceps brachii is near optimal length for force production when the elbow is flexed at 90°. As
a result, most investigators 1,4,13 use an apparatus to fix the arm in this position. The electrodes are then
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placed over the motor point of the biceps brachii midway between the bicipital groove and the elbow crease
and the distal biceps tendon 1,13. Behm et al.4 used slightly different placement of the distal electrode,
securing it to the proximal, anterior portion of the forearm flexors.
The triceps surae have been evaluated using two, slightly different placements of the electrodes,
depending on which particular muscles the investigators were trying to stimulate. When exciting the triceps
surae as a group, the tibial nerve is typically the target for stimulation. The electrodes are therefore placed
in the popliteal fossa and at the distal triceps surae where it intersects the tendon 4,6,14. Aagaard et al.15 and
Bigland-Ritchie et al.12 focused specifically on activation of the soleus, and placed one of the electrodes
just distal to the gastrocnemius. The other electrode was placed either ~13cm proximal to the calcaneous15
or over the Achilles’ tendon at the malleolus12.
The quadriceps femoris have been extensively investigated using electrical stimulation. Since this
muscle group is involved in activities such as rising from a chair and locomotion, activation is of prime
importance. Many studies have used the percutaneous superimposed electrical stimulation technique (PES)
to activate the quadriceps by stimulating the muscle bellies of the anterior thigh. Electrode placement for
this technique has been reported without specific detail, or at similar, but slightly varying positions of the
proximal and distal anterior thigh2-4,6,7,9,16-20. Dudley et al 17 and Kendall et al 7 placed 4.1 x 8.8-cm and 8 x
10-cm electrodes (respectively) distally over the vastus medialis and the proximally over the vastus
lateralis. Additionally, studies have been investigated using the ITT to stimulate the quadriceps. In this
case, the femoral nerve was stimulated with the cathode over the femoral triangle above the femoral nerve
and the anode placed transversely over the gluteal fold 21,22.
Interpolated Twitch Technique v. Percutaneous Superimposed Electrical Stimulation Technique
Over many years of critical analysis of superimposed electrical stimulation methods, two
techniques have become generally accepted for producing reliable results. While both techniques are able
to activate the muscle, variation occurs in the location of stimulation. The ITT activates the muscle by
stimulating the motor units with a twitch applied to the muscle nerve, whereas with the PES, the muscle is
stimulated by electrodes placed directly on the muscle belly. Paillard et al 5noted the greatest drawback of
the superimposed technique is the high level of pain that is inflicted with the electrical stimulation; if the
stimulation of the muscle is too great, this could result in activation of the antagonist muscles. Paillard
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concluded through analysis of the available literature that ITT was used most often for evaluation purposes
while the PES was typically applied in training programs 5.
Muscle action
There seems to be little or no influence of each muscles said actions (flexion or extension)
affecting the results of activation when measured using interpolated twitch. The biceps brachii are flexors
of the arm, the quadriceps femoris are extensors of the knee, and the adductor pollicis muscle in the hand
adducts the thumb; all three muscles (muscle groups) have been described as capable of full activation1,12.
In contrast, Behm et al.6 suggested that when comparing the dorsiflexors of the foot with the plantar
flexors, the dorsiflexors had a greater capacity to achieve full activation. It can be inferred that while there
are a number of muscles that reportedly cannot voluntarily reach full activation, there is no apparent
correlation between the action of the muscle and its ability to do so.
ITT parameters: intensity, frequency, timing, and number of stimulation
The variables of percutaneous electrical stimulation delivered during ITT have been greatly varied
between studies. The intensity of the stimuli is measured in volts (v), and milliamps (mA). Reports of these
measures have ranged from 100-400v at 10mA-1A. The frequencies of stimulation vary between 10100Hz. Generally, 200-300µs pulses are administered 10-2000µs apart. The number of stimuli has ranged
from single tetanus to octets.
PHYSIOLOGY
Different muscles
The proportion of fiber types within each muscle and the elastic characteristics of its tendons seem
to have a great impact on the muscle’s ability to reach full activation with voluntary contractions 5.
According to Henneman’s size principle, MU will be recruited from smallest to largest in relationship to
the intensity of stimulation applied. Fast twitch fibers are able to produce more force at a faster rate than
slow oxidative fibers. As a result, if the muscle is maximally stimulated, whether voluntarily or
involuntarily, muscles that have a greater percentage of fast twitch fibers (more fast twitch MU), have an
increased opportunity for maximal activation. Behm et al.4 concluded that dorsiflexors of the foot have a
greater capacity for complete activation than the plantar flexors due to the faster twitch of the MU in the
muscles.
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Support for ability to increase MVC
The amplitude of MVC depends on several factors that together affect the performance of the
muscle. MVCs are directly related to α-motoneuron excitability, neural drive, MU recruitment, and
motoneuron firing frequencies, among other things. Without optimal levels of all these elements, the
muscle can still establish a contraction, however, when these variables increase, it directly results in an
increase in MVC. While hypertrophy (increase in cross-sectional area of the muscle) typically has a
positive relationship with strength, hypertrophy doesn’t correlate with increases in MVC, as these increases
typically occur as a result of central and peripheral neural adaptations15.
Different muscle actions
Several muscles have been studied with various types of electrical stimulation attempting to find
the most accurate and reliable way to measure the contractility of the muscles. One of the variables in these
investigations is the action being completed by the muscle while measurements are collected. According to
Paillard et al 5, activation levels of each muscle are strongly influenced by the muscle action performed
during testing. Overall, studies with healthy subjects who performed isometric contractions generally
reported similar peak torque scores during voluntary and evoked contractions. PES trials requiring
concentric muscle contractions during evaluation produced comparable or lesser peak torque values than
voluntary contractions. In comparison, few studies have examined torque with eccentric muscle actions.
However, some studies have suggested that voluntary actions will either be limited or improved due to
neural protection of the muscles through mechanisms such as the golgi tendon organs (GTO), muscle
spindles, and coactivation. Nonetheless, superimposed electrical stimulation creates physiological effects
which are directly related to the mode of muscle action 5.
Healthy subjects
The results of many prior studies using superimposed electrical stimulation have been collected
from healthy subjects1,2,7,9,12-16,18-25. These findings, while some are still inconclusive, are estimates of the
musculoskeletal system’s maximal physiological capacity. Because the subjects were reportedly healthy
during participation, inferences can be made about trends and could provide critical baseline measures for
future investigations with special populations.
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Special populations
To date, few studies have explored PES or ITT methods to evaluate special populations.
Specifically, physiological changes evolve with the onset and progression of neurological disorders which
could be assessed and monitored using healthy subjects’ measures to establish a baseline. Because of
reliability deficiencies in methods used in the past, electrical stimulation has not yet been used for this
purpose2,7. There are several movement disorders that degenerate or alter central activation of motor
control. Parkinson’s Disease, Progressive Supranuclear Palsy, and Huntington’s Disease, just to name a
few, could all use the superimposed technique to monitor progression of the disease or progress in
counteracting the disease as well as to measure degeneration of muscle activation capabilities.
ADAPTATIONS TO RESISTANCE TRAINING
Increased maximal voluntary activation
As it has been well established in the literature, resistance training triggers an increase in strength
of the involved muscles. In fact, the initial onset of the increase has been determined to be the result of
neural adaptations, not physiological adaptations (hypertrophy) of the muscle itself. Some studies have
assessed muscle activation in terms of this adaptive response and have found that resistance training
increases levels of activation as well as maximal motor unit firing rate, although there was a weak
correlation between the two variables 3.
Aagaard et al.15 investigated amplitudes of the V-wave in pre- and post-14 wk resistance training
regimens. When supramaximal nerve stimulation is applied during MVC, the efferent motor impulses
generated because of activation of motoneurons via central descending pathways will collide with the
antidromic potentials, thus allowing a part of the evoked reflex response to pass to the muscle, called the Vwave. It’s been termed the V-wave to indicate its presence during voluntary efforts, but not at rest15.
The subjects were put through a progressive heavy-resistance strength training program which
resulted in elevated V-wave amplitudes, indicating neurological adaptations at spinal and supraspinal
levels. The study identifies the possibility that these neural changes could implicate transformations in αmotoneuron excitability and descending motor drive. The increased amplitude of the V-wave in response to
resistance training is indicative of amplified neural drive in descending corticospinal pathways which is
paralleled by an increase in motor neuron excitability. The study reports as much as 49% increases in V-
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wave amplitude in response to 9-21 wk of heavy-resistance strength training. The investigators suggest that
this increase is the consequence of increases in motoneuron firing frequency and/or motoneuron
recruitment. The conclusion that heavy-resistance strength training initiates a considerable increase in
efferent motor output during MVC suggests that further studies should be done to investigate the this
positive outcome15.
Dynamic versus isometric testing
Typically, to measure activation within a muscle through isometric contraction the evoked
response is calculated by finding the difference between the peak force (PF) following MVC plus
superimposed twitch and the PF of MVC. This approach is fairly straightforward and reliable when testing
multiple sessions and has been frequently used. When testing with dynamic actions such as concentric
contractions, force trace preceding stimulation is inferred to suggest an approximation of what the
voluntary force would have been when evoked force reaches its peak 26. These numbers are somewhat
arbitrary and this method has produced a negligible effect on estimations of voluntary activation when
applied to isometric contractions1. Although isometric testing is less specific to dynamic training, the
method of estimating voluntary activation of the muscle isometrically is far more accurate than testing with
dynamic exercises.
Increased maximal rate of force development (MRFD)
When rationalizing an increase in MRFD, several factors seem to play a role in decreasing the
amount of time required to reach maximal force. Aagaard et al.15 reported that following 14 wk of
resistance training, the results suggested increases in efferent motor output, enhanced neural drive, and
increased motoneuron excitability which produce increases in MVC. When more signals are sent with
greater intensity to motoneurons which are increasingly accepting of the signals to stimulate the muscle, it
seems logical that the muscle would respond by producing force at a faster rate. Although there will be an
expected plateau at some point as the MRFD increases with resistance training, no longitudinal studies
have been conducted to measure at what point this occurs. Further studies could investigate what
specifically increases each factor to reach optimal MRFD for individuals.
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Using PES in special populations: A case example of Parkinson’s Disease
Parkinson’s Disease (PD) is a central nervous system (CNS) disorder that results in reduced
strength 27among other disabling symptoms. Miscommunication within the nervous system of persons with
PD first occurs deep within the brain, where the production of chemicals, called neurotransmitters, is
altered by the disease. From there motor-control messages are encrypted with problems along the way,
which result in either the message never reaching the muscle or the message being misrepresented by the
time it gets there. Nallegowda et al 28 has demonstrated that strength deficits are at least partially central in
nature, but techniques such as ITT and PES have not yet been used on this population.
As a result of the impairment of neurological efficiency when a message relaying motor-control is
sent from the brain to initiate a voluntary movement, an individual with PD would be expected to have
decreased MVC. However, if the muscle were directly stimulated using ITT or PES, the involuntary
activation should still be maximal because the PD has not been found to damage the peripheral nervous
system. Thus, persons with PD should have a reduced CAR, but this has yet to be determined. Also, PES
may be able to give us more information about the adaptations in the CNS with strength training in persons
with CNS disorders.
CONCLUSIONS
Due to the neuromuscular stress when an individual engages in resistance training, the body reacts
quickly by adapting the neurological pathways for communication between the muscle and the central
nervous system (spinal cord and brain), causing changes to occur both at the periphery and centrally. The
neurological adaptations that take place can be identified and evaluated by methods including ITT and PES.
Following decades of critical analysis of the techniques used to interpret muscle contractility and its
relationship to the nervous system, general conclusions can be made regarding the ability to stimulate
different muscles and the most reliable methods can be elucidated from the many methodologies that have
already been explored. Studies have been conducted to measure these effects on healthy populations, but
there remain endless possibilities for further investigation involving neurological impairment.
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